WEP Clinical Ltd. (“WEP”) is a leading pharmaceutical services platform specializing in expanded access and named patient programs which enable drug developers to create broader treatment access solutions for patients worldwide. WEP leverages its expertise in the physical, legal and regulatory aspects of global pharmaceutical product access and distribution across its connected suite of services, which, in addition to expanded access and named patient programs, include market access solutions, home nursing services for decentralized clinical trials and clinical trial sourcing.